Physician profile
Sara Thomatis
NPI 1326408774
$3,065.61
in general payments reported to CMS, 2019-2025
34 companies · $482 in 2025
The $482 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $311 · 2021: $530 · 2022: $582 · 2023: $950 · 2024: $211 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595 · Gift: $47.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.32 |
| Gift | $47.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $783.08 | 2020-2025 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $245.66 | 2020-2025 | Thinprep 2000 Processor, Omni Hysteroscope, Aptima |
| Exeltis, USA INC. | $204.46 | 2020-2025 | Slynd |
| Organon LLC | $181.02 | 2021-2025 | Jada System |
| Daiichi Sankyo INC. | $169.34 | 2020-2024 | Injectafer |
| Astellas Pharma US INC | $142.60 | 2023-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $132.92 | 2021-2023 | Bulkamid, Axonics |
| Medical Device Business Services, INC. | $125.00 | 2023 | Vistaseal |
| Dysis Medical, INC. | $119.09 | 2021-2022 | |
| Intuitive Surgical, INC. | $116.55 | 2020-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $106.58 | 2023-2024 | Upsylon, Advantage System |
| Mayne Pharma Commercial LLC | $62.97 | 2022-2023 | |
| Evofem Biosciences, INC. | $62.53 | 2022 | |
| Therapeuticsmd, INC. | $60.79 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.50 | 2020-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $50.76 | 2025 | Fibryga |
| Caldera Medical, INC | $47.53 | 2023 | Desara |
| Coopersurgical, INC. | $46.63 | 2020-2025 | Paragard T 380a |
| Avion Pharmaceuticals | $33.39 | 2021-2022 | |
| Pfizer INC. | $32.23 | 2023-2024 | |
| Sage Therapeutics, LLC | $31.75 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $31.34 | 2025 | Myfembree |
| Minerva Surgical, INC | $29.70 | 2023-2025 | |
| Conmed Corporation | $26.79 | 2023 | Conmed Specimen Retrieval, Airseal |
| Biohaven Pharmaceutical Holding Company LTD. | $25.59 | 2022 | |
| Becton, Dickinson and Company | $21.55 | 2024 | Bd Onclarity |
| Agile Therapeutics, INC. | $16.95 | 2021 | |
| Allergan, INC. | $16.51 | 2021 | |
| Mckesson Medical-Surgical, INC. | $15.95 | 2025 | |
| Exact Sciences Corporation | $15.77 | 2023 | Cologuard Collection Kit |
| Medicem INC. | $15.35 | 2023 | |
| Myovant Sciences INC. | $15.05 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.00 | 2025 | Qelbree |
| Scynexis, INC. | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Thomatis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.